Calvo Martínez, L. (2014). Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: Results from the GEICAM/2006-14 trial.
Citación estilo ChicagoCalvo Martínez, Lourdes. Trastuzumab or Lapatinib With Standard Chemotherapy for HER2-positive Breast Cancer: Results From the GEICAM/2006-14 Trial. 2014.
Cita MLACalvo Martínez, Lourdes. Trastuzumab or Lapatinib With Standard Chemotherapy for HER2-positive Breast Cancer: Results From the GEICAM/2006-14 Trial. 2014.
Precaución: Estas citas no son 100% exactas.